Pacific Edge (ASX:PEB, NZE:PEB) received notification from Medicare Administrative Contractor (MAC) Novitas that an expert panel will be convened to review coverage for tests, including Cxbladder Triage, according to a Monday filing with the New Zealand and Australian bourses.
The review will focus on tests referenced in the 2025 update to the American Urological Association (AUA) microhematuria guideline, the filing said.
The contractor advisory committee, made up of urology experts, is set to convene in early 2026 to align Medicare policy with the 2025 AUA guideline update, per the filing.